bf/NASDAQ:HALO_icon.jpeg

COM:HALOZYME

Halozyme Therapeutics, Inc.

  • Stock

USD

Last Close

45.70

22/11 21:00

Market Cap

6.74B

Beta: -

Volume Today

4.55M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
4.42M
-
6.29M
42.25%
7.95M
26.39%
12.06M
51.70%
9.88M
18.01%
13.89M
40.48%
25.99M
87.19%
45.05M
73.33%
57.33M
27.24%
77.02M
34.34%
113.86M
47.84%
average payables
2.70M
-
3.07M
13.53%
3.75M
22.23%
4.04M
7.66%
5.76M
42.70%
6.01M
4.35%
5.26M
12.59%
4.18M
20.46%
1.73M
58.51%
9.62M
454.45%
14.75M
53.42%
average receivables
12.40M
-
9.12M
26.43%
20.78M
127.77%
24.05M
15.72%
18.91M
21.37%
26.07M
37.88%
44.72M
71.56%
78.59M
75.72%
94.35M
20.06%
161.02M
70.66%
232.64M
44.48%
book value per share
-0.18
-
0.34
290.19%
0.34
0.69%
-0.25
174.80%
1.53
701.74%
1.73
13.47%
0.64
63.32%
1.11
74.42%
1.40
26.28%
1.24
11.39%
0.62
49.67%
capex per share
-0.02
-
-0.01
45.25%
-0.02
67.05%
-0.02
31.61%
-0.01
59.63%
-0.03
228.14%
-0.03
13.80%
-0.02
34.32%
-0.01
43.65%
-0.04
239.30%
-0.11
224.23%
capex to depreciation
-1.87
-
-0.78
58.54%
-1.41
81.26%
-1.30
7.50%
-0.62
52.01%
-1.95
212.57%
-0.99
49.14%
-0.76
23.22%
-0.49
36.24%
-0.10
80.07%
-0.18
86.01%
capex to operating cash flow
0.05
-
0.03
38.18%
0.06
121.06%
0.06
2.17%
-0.01
116.17%
0.09
1,035.41%
0.05
49.80%
-0.05
195.48%
-0.00
89.22%
-0.02
311.70%
-0.04
96.48%
capex to revenue
-0.04
-
-0.02
56.69%
-0.02
3.77%
-0.02
22.38%
-0.00
80.06%
-0.03
620.13%
-0.02
32.87%
-0.01
54.60%
-0.00
64.88%
-0.01
121.70%
-0.02
153.11%
cash per share
0.63
-
1.11
74.39%
0.86
22.65%
1.60
87.34%
3.44
114.72%
2.47
28.22%
2.92
18.22%
2.70
7.43%
5.27
94.97%
2.65
49.67%
2.50
5.56%
days of inventory on hand
360.57
-
102.86
71.47%
118.43
15.14%
160.74
35.72%
60.29
62.49%
814.73
1,251.26%
235.28
71.12%
511.28
117.31%
241.69
52.73%
262.34
8.55%
242.12
7.71%
days payables outstanding
183.19
-
48.22
73.68%
56.15
16.45%
39.33
29.96%
93.12
136.78%
146.89
57.73%
51.56
64.90%
16.23
68.53%
6.91
57.42%
46.36
571.01%
22.42
51.64%
days sales outstanding
60.59
-
44.33
26.84%
87.59
97.60%
39.02
55.46%
25.52
34.60%
72.12
182.64%
110.70
53.50%
133.30
20.42%
74.90
43.81%
127.77
70.57%
103.09
19.32%
debt to assets
0.49
-
0.30
38.56%
0.27
8.75%
0.83
202.17%
0.39
53.02%
0.29
26.24%
0.71
147.83%
0.68
3.72%
0.79
15.89%
0.82
3.03%
0.86
5.76%
debt to equity
-2.49
-
1.21
148.43%
1.16
3.88%
-6.67
675.46%
0.97
114.56%
0.51
47.71%
4.39
763.99%
2.63
40.06%
4.45
69.26%
8.87
99.27%
17.89
101.68%
dividend yield
0.01
-
0.01
96.05%
0.00
79.66%
0.00
-
earnings yield
-0.05
-
-0.06
16.98%
-0.01
74.58%
-0.08
455.14%
0.02
127.96%
-0.04
267.82%
-0.03
26.17%
0.02
178.60%
0.07
220.91%
0.03
63.54%
0.06
118.70%
enterprise value
1.71B
-
1.17B
31.57%
2.20B
87.84%
1.41B
35.79%
2.80B
97.82%
2.17B
22.45%
2.84B
30.98%
6.07B
113.52%
6.41B
5.71%
9.06B
41.24%
6.34B
30.00%
enterprise value over ebitda
-21.30
-
-18.60
12.69%
-80.22
331.33%
-16.99
78.82%
34.54
303.21%
-31.29
190.60%
-42.03
34.31%
42.06
200.07%
23.24
44.73%
29.16
25.43%
15.01
48.52%
ev to operating cash flow
-34.73
-
-24.67
28.95%
-59.39
140.70%
-28.07
52.74%
20.87
174.35%
-43.82
310.00%
-33.26
24.10%
109.40
428.91%
21.42
80.42%
37.73
76.14%
16.32
56.75%
ev to sales
31.27
-
15.56
50.22%
16.31
4.78%
9.64
40.88%
8.84
8.35%
14.28
61.67%
14.50
1.49%
22.67
56.39%
14.47
36.19%
13.72
5.15%
7.65
44.28%
free cash flow per share
-0.46
-
-0.40
12.95%
-0.31
21.87%
-0.42
34.35%
0.97
332.58%
-0.38
138.77%
-0.62
64.34%
0.39
162.72%
2.12
445.00%
1.72
18.84%
2.78
61.77%
free cash flow yield
-0.03
-
-0.04
35.21%
-0.02
56.50%
-0.04
135.66%
0.05
213.42%
-0.03
153.70%
-0.03
35.60%
0.01
126.04%
0.05
478.88%
0.03
42.65%
0.08
149.04%
graham net net
-0.36
-
0.17
147.97%
-0.01
106.43%
-0.55
4,850.31%
1.30
337.12%
1.37
5.84%
0.04
96.76%
0.31
607.20%
-0.51
261.46%
-7.93
1,463.31%
-8.00
0.89%
graham number
1.72
-
2.06
19.68%
1.39
32.21%
2.14
53.86%
3.98
85.74%
4.67
17.27%
2.68
42.71%
4.86
81.73%
9.50
95.32%
6.42
32.39%
5.43
15.44%
income quality
0.59
-
0.69
17.58%
1.15
65.55%
0.49
57.49%
2.13
335.30%
0.62
71.05%
1.18
91.90%
0.43
63.67%
0.74
73.09%
1.19
59.76%
1.38
16.16%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0.52
Infinity%
0.51
1.09%
interest coverage
-24.57
-
-11.29
54.02%
-5.28
53.27%
-4.17
21.09%
3.68
188.46%
-3.84
204.30%
-5.81
51.32%
7.08
221.74%
36.66
417.87%
15.79
56.94%
17.99
13.97%
interest debt per share
0.47
-
0.45
3.91%
0.43
3.88%
1.85
325.68%
1.64
11.06%
1.01
38.84%
2.87
185.36%
3.07
6.83%
6.29
105.05%
11.13
77.04%
11.31
1.64%
inventory turnover
1.01
-
3.55
250.55%
3.08
13.15%
2.27
26.32%
6.05
166.59%
0.45
92.60%
1.55
246.28%
0.71
53.98%
1.51
111.55%
1.39
7.87%
1.51
8.35%
invested capital
-2.49
-
1.21
148.43%
1.16
3.88%
-6.67
675.46%
0.97
114.56%
0.51
47.71%
4.39
763.99%
2.63
40.06%
4.45
69.26%
8.87
99.27%
17.89
101.68%
market cap
1.69B
-
1.18B
29.98%
2.20B
85.46%
1.26B
42.42%
2.76B
118.61%
2.10B
23.99%
2.56B
21.81%
5.82B
127.33%
5.66B
2.78%
7.79B
37.68%
4.96B
36.30%
net current asset value
-26.59M
-
36.70M
238.02%
32.98M
10.12%
-37.46M
213.59%
198.79M
630.62%
236.49M
18.96%
69.33M
70.68%
125.89M
81.58%
18.81M
85.06%
-932.70M
5,058.27%
-903.04M
3.18%
net debt to ebitda
-0.28
-
0.18
165.63%
-0.24
230.28%
-1.80
655.84%
0.41
123.04%
-0.99
337.92%
-4.18
323.11%
1.73
141.41%
2.75
58.82%
4.09
49.02%
3.27
20.15%
net income per share
-0.74
-
-0.56
24.69%
-0.25
54.35%
-0.81
216.49%
0.46
157.33%
-0.56
221.19%
-0.50
10.53%
0.95
289.35%
2.86
202.12%
1.48
48.41%
2.10
42.06%
operating cash flow per share
-0.44
-
-0.39
11.45%
-0.29
24.43%
-0.39
34.53%
0.98
349.58%
-0.34
135.08%
-0.59
71.70%
0.41
168.79%
2.13
422.93%
1.75
17.59%
2.90
65.02%
payables turnover
1.99
-
7.57
279.93%
6.50
14.13%
9.28
42.77%
3.92
57.77%
2.48
36.60%
7.08
184.88%
22.49
217.75%
52.83
134.88%
7.87
85.10%
16.28
106.77%
receivables turnover
6.02
-
8.23
36.69%
4.17
49.39%
9.36
124.50%
14.31
52.91%
5.06
64.62%
3.30
34.85%
2.74
16.96%
4.87
77.97%
2.86
41.37%
3.54
23.94%
research and ddevelopement to revenue
1.76
-
1.06
40.01%
0.69
34.74%
1.03
48.95%
0.48
53.73%
0.99
107.95%
0.72
27.39%
0.13
82.19%
0.08
37.11%
0.10
25.39%
0.09
8.74%
return on tangible assets
-0.82
-
-0.41
49.77%
-0.18
56.96%
-0.39
122.19%
0.12
130.74%
-0.18
250.66%
-0.13
30.04%
0.22
274.36%
0.36
63.81%
0.23
37.42%
0.33
46.29%
revenue per share
0.49
-
0.61
26.40%
1.07
73.60%
1.15
7.54%
2.32
102.46%
1.06
54.43%
1.36
28.41%
1.96
44.68%
3.15
60.44%
4.82
53.04%
6.18
28.10%
roe
4.18
-
-1.65
139.60%
-0.75
54.67%
3.17
523.15%
0.30
90.47%
-0.32
206.80%
-0.79
143.91%
0.85
208.56%
2.04
139.26%
1.19
41.78%
3.36
182.26%
roic
-2.77
-
-0.73
73.63%
-0.33
55.04%
-0.46
39.32%
0.20
144.11%
-0.19
192.27%
-0.14
26.48%
0.26
292.09%
0.42
58.54%
0.13
68.87%
0.17
32.99%
sales general and administrative to revenue
0.59
-
0.48
19.18%
0.30
37.88%
0.31
5.47%
0.17
45.62%
0.40
135.56%
shareholders equity per share
-0.18
-
0.34
290.19%
0.34
0.69%
-0.25
174.80%
1.53
701.74%
1.73
13.47%
0.64
63.32%
1.11
74.42%
1.40
26.28%
1.24
11.39%
0.62
49.67%
stock based compensation to revenue
0.17
-
0.20
16.49%
0.15
23.90%
0.17
13.04%
0.10
44.46%
0.24
142.65%
0.18
24.51%
0.06
63.77%
0.05
26.95%
0.04
21.31%
0.04
19.49%
tangible asset value
-19.99M
-
41.35M
306.86%
43.00M
3.98%
-32.48M
175.54%
208.37M
741.50%
248.89M
19.45%
91.77M
63.13%
151.05M
64.60%
196.95M
30.39%
-785.90M
499.03%
-805.89M
2.54%
tangible book value per share
-0.18
-
0.34
290.19%
0.34
0.69%
-0.25
174.80%
1.53
701.74%
1.73
13.47%
0.64
63.32%
1.11
74.42%
1.40
26.28%
-5.74
510.12%
-6.01
4.57%
working capital
69.74M
-
136.99M
96.42%
109.31M
20.20%
201.95M
84.74%
379.04M
87.69%
278.49M
26.53%
457.80M
64.39%
133.38M
70.87%
809.14M
506.65%
608.22M
24.83%
633.93M
4.23%

All numbers in USD (except ratios and percentages)